Literature DB >> 27480945

Bladder cancer: Targeted agents reverse chemotherapy resistance in urothelial carcinoma.

Peter Sidaway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27480945     DOI： 10.1038/nrurol.2016.138

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder.

Authors:  Wei-Jan Wang; Chien-Feng Li; Yu-Yi Chu; Yu-Hui Wang; Tzyh-Chyuan Hour; Chia-Jui Yen; Wen-Chang Chang; Ju-Ming Wang
Journal:  Clin Cancer Res       Date:  2016-07-19       Impact factor: 12.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.